Click Here for 5% Off Your First Aladdin Purchase!

Pirfenidone - ≥98%(GC), high purity , CAS No.53179-13-8

  • Moligand™
  • ≥98%(GC)
Item Number
P129335
Grouped product items
SKUSizeAvailabilityPrice Qty
P129335-100mg
100mg
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$9.90
P129335-250mg
250mg
In stock
$16.90
P129335-1g
1g
In stock
$39.90
P129335-5g
5g
In stock
$119.90
P129335-25g
25g
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
$319.90
P129335-100g
100g
In stock
$899.90

anti-inflammatory antifibrotic agent

Basic Description

SynonymsPIRFENIDONE|53179-13-8|5-methyl-1-phenylpyridin-2(1H)-one|Esbriet|Deskar|Pirespa|AMR-69|5-Methyl-1-phenyl-2-(1H)-pyridone|Pirfenidona|Pirfenidonum|2(1H)-Pyridinone, 5-methyl-1-phenyl-|AMR 69|5-Methyl-1-phenyl-2(1H)-pyridone|5-methyl-1-phenyl-2(1H)-pyridin
Specifications & PurityMoligand™, ≥98%(GC)
Biochemical and Physiological MechanismsPirfenidone inhibits collagen production and fibroblast proliferation. It has shown antifibrotic and anti-inflammatory properties in variety of animal models of pulmonary fibrosis, and in clinical trials.Orally active anti-inflammatory, antifibrotic and a
Shipped InNormal
GradeMoligand™
NoteWherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
Product Description

Application:

Pyrfenidone is used for:
1、 As a postoperative eye drop for rabbits, analyze its anti fibrotic effect and improve glaucoma filtration surgery.
2、As an anti scarring agent, check if it affects the foreign body reaction after implantation of glaucoma drainage device (GDD) in rabbits.
3、Test its anti fibrotic potential in primary culture of human orbital fibroblasts (hOF).
4、 As tumor necrosis factor (TNF) α) Inhibitors, studying their role in hypoxia.

Explanation:

Pyrfenidone (5-methyl-1-phenyl-2- [1H] - pyridone) is a synthesized pyridine derivative.

Product Properties

ALogP1.9

Associated Targets

C7orf77 Tdark Uncharacterized protein C7orf77 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP1A2 Tchem Cytochrome P450 1A2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2D6 Tclin Cytochrome P450 2D6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CNR1 Tclin Cannabinoid receptor 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP2C19 Tchem Cytochrome P450 2C19 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD1 Tclin D(1A) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD2 Tclin D(2) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A4 Tclin Cytochrome P450 3A4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ESR1 Tclin Estrogen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EHMT2 Tchem Histone-lysine N-methyltransferase EHMT2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NR3C1 Tclin Glucocorticoid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A5 Tclin Cytochrome P450 3A5 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AVPR1A Tclin Vasopressin V1a receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HDAC6 Tclin Histone deacetylase 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HRH1 Tclin Histamine H1 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A2 Tclin Sodium-dependent noradrenaline transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A3 Tclin Sodium-dependent dopamine transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A4 Tclin Sodium-dependent serotonin transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE4D Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4D 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE3A Tclin cGMP-inhibited 3',5'-cyclic phosphodiesterase A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGS1 Tclin Prostaglandin G/H synthase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGS2 Tclin Prostaglandin G/H synthase 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD3 Tclin D(3) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM3 Tclin Muscarinic acetylcholine receptor M3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2B Tclin Alpha-2B adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM2 Tclin Muscarinic acetylcholine receptor M2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2C Tclin Alpha-2C adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2A Tclin 5-hydroxytryptamine receptor 2A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA2A Tclin Adenosine receptor A2a 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM1 Tclin Muscarinic acetylcholine receptor M1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2A Tclin Alpha-2A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRB1 Tclin Beta-1 adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA1A Tclin Alpha-1A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AR Tclin Androgen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MAOA Tclin Amine oxidase [flavin-containing] A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2C Tclin 5-hydroxytryptamine receptor 2C 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA1 Tclin Adenosine receptor A1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR1A Tclin 5-hydroxytryptamine receptor 1A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA3 Tchem Adenosine receptor A3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR3A Tclin 5-hydroxytryptamine receptor 3A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2B Tclin 5-hydroxytryptamine receptor 2B 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EDNRA Tclin Endothelin-1 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRD1 Tclin Delta-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRK1 Tclin Kappa-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRM1 Tclin Mu-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MLNR Tchem Motilin receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

Pubchem Sid488183324
Pubchem Sid Urlhttps://pubchem.ncbi.nlm.nih.gov/substance/488183324
IUPAC Name 5-methyl-1-phenylpyridin-2-one
INCHI InChI=1S/C12H11NO/c1-10-7-8-12(14)13(9-10)11-5-3-2-4-6-11/h2-9H,1H3
InChi Key ISWRGOKTTBVCFA-UHFFFAOYSA-N
Canonical SMILES CC1=CN(C(=O)C=C1)C2=CC=CC=C2
Isomeric SMILES CC1=CN(C(=O)C=C1)C2=CC=CC=C2
WGK Germany 3
RTECS UV1148200
PubChem CID 40632
Molecular Weight 185.22
Beilstein 21(5)7,197
Reaxy-Rn 1526549

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

32 results found

Lot NumberCertificate TypeDateItem
I2226093Certificate of AnalysisJul 11, 2024 P129335
I2226091Certificate of AnalysisJul 11, 2024 P129335
I2226090Certificate of AnalysisJul 11, 2024 P129335
G2425684Certificate of AnalysisJul 10, 2024 P129335
G2425654Certificate of AnalysisJul 10, 2024 P129335
G2425653Certificate of AnalysisJul 10, 2024 P129335
G2425652Certificate of AnalysisJul 10, 2024 P129335
F2218061Certificate of AnalysisApr 02, 2024 P129335
B2216011Certificate of AnalysisDec 20, 2023 P129335
G2326927Certificate of AnalysisJul 07, 2023 P129335
G2326919Certificate of AnalysisJul 07, 2023 P129335
G2326916Certificate of AnalysisJul 07, 2023 P129335
G2326915Certificate of AnalysisJul 07, 2023 P129335
G2326913Certificate of AnalysisJul 07, 2023 P129335
G2326912Certificate of AnalysisJul 07, 2023 P129335
G2326909Certificate of AnalysisJul 07, 2023 P129335
G2326908Certificate of AnalysisJul 07, 2023 P129335
G23261374Certificate of AnalysisJul 07, 2023 P129335
G23261370Certificate of AnalysisJul 07, 2023 P129335
A1612032Certificate of AnalysisJun 08, 2023 P129335
B2108105Certificate of AnalysisDec 14, 2022 P129335
K2011046Certificate of AnalysisSep 17, 2022 P129335
K2011044Certificate of AnalysisSep 17, 2022 P129335
D2324141Certificate of AnalysisJul 18, 2022 P129335
D2321339Certificate of AnalysisJul 18, 2022 P129335
I2226092Certificate of AnalysisJul 18, 2022 P129335
I2226094Certificate of AnalysisJul 18, 2022 P129335
F2218062Certificate of AnalysisJun 24, 2022 P129335
F2218063Certificate of AnalysisJun 24, 2022 P129335
C2020021Certificate of AnalysisJan 25, 2022 P129335
B2216010Certificate of AnalysisDec 08, 2021 P129335
B2215427Certificate of AnalysisDec 08, 2021 P129335

more

Chemical and Physical Properties

SolubilitySoluble in water (>10 mg/ml at 60 °C), chloroform, DMSO (>20 mg/ml), ethanol, and DMF.
Melt Point(°C)107.0 to 111.0 °C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H302:Harmful if swallowed

Precautionary Statements

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P330:Rinse mouth.

P301+P317:IF SWALLOWED: Get medical help.

WGK Germany 3
RTECS UV1148200
Reaxy-Rn 1526549

Related Documents

References

1. García L, Hernández I, Sandoval A, Salazar A, Garcia J, Vera J, Grijalva G, Muriel P, Margolin S, Armendariz-Borunda J.  (2002)  Pirfenidone effectively reverses experimental liver fibrosis..  J Hepatol,  37  (6): (797-805).  [PMID:12445421]
2. Macías-Barragán J, Sandoval-Rodríguez A, Navarro-Partida J, Armendáriz-Borunda J.  (2010)  The multifaceted role of pirfenidone and its novel targets..  Fibrogenesis Tissue Repair,  (3): (16).  [PMID:20809935]
3. Conte E, Gili E, Fagone E, Fruciano M, Iemmolo M, Vancheri C.  (2014)  Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts..  Eur J Pharm Sci,  58  (3): (13-9).  [PMID:24613900]
4. King Jr TE, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L et al..  (2014)  A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis..  N Engl J Med,  370  (22): (2083-92).  [PMID:24836312]
5. Westermeyer HD et al..  (2019)  Safety and efficacy of topically applied 0.5% and 1% pirfenidone in a canine model of subconjunctival fibrosis.  Vet Ophthalmol,      [PMID:701645]

Solution Calculators